Abstract
We are currently characterizing mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis type II). Surprisingly, all 17 patients with a mutation in exon III of the IDS gene identified by us were found to carry both the mutant and wild-type sequences in polymerase chain reaction (PCR) products amplified from genomic DNA. Similarly, two unaffected male controls showed a heterozygous pattern for two different point mutations in exon III. Collectively, the data suggest that at least intron 2, exon III, and the 3′-half of exon II of the functional IDS gene are present in the human genome as (part of) a non-expressed IDS gene. Deletion map** further suggests that the pseudogene is in distal Xq in physical proximity to the functional IDS gene. The high degree of sequence homology observed between the functional IDS gene and pseudogene results in permanent co-amplification in PCR-based screening methods and makes mutation analysis at the genomic DNA level difficult.
Similar content being viewed by others
References
Bunge S, Steglich C, Beck M, Rosenkranz W, Schwinger E, Hopwood JJ, Gal A (1992) Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet 1:335–339
Bunge S, Steglich C, Zuther C, Beck M, Morris CP, Schwinger E, Schinzel A, Hopwood JJ, Gal A (1993) Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet 2:1871–1875
Flomen RH, Green EP, Green PM, Bentley DR, Giannelli F (1993) Determination of the organization of coding sequences within the iduronate sulphate sulphatase (IDS) gene. Hum Mol Genet 2:5–10
Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, Gal A (1993) Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat 2:435–442
Naylor J, Brinke A, Hassock S, Green PM, Giannelli F (1993) Characteristic mRNA abnormality found in half of the patients with severe haemophilia A is due to large DNA inversions. Hum Mol Genet 2:1773–1778
Palmieri G, Capra V, Romano G, D'Urso M, Johnson S, Schlessinger D, Morris P, Hopwood J, Di Natale P, Gatti R, Ballabio A (1992) The iduronate sulfatase gene: isolation of a 1. 2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome. Genomics 12:52–57
Popowska E, Rathmann M, Tylki-Szymanska A, Bunge S, Steglich C, Schwinger E, Gal A (1994) Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mutat (in press)
Rathmann M, Popowska E, Bunge S, Beck M, Hopwood JJ, Schwinger E, Gal A (1994) Mutation ‘hot spots’ in the iduronate-sulfatase gene, and evidence for a pseudogene (abstract). Am J Hum Genet 55:A238
Steén-Bondeson M-L, Dahl N, Tönnesen T, Kleijer WJ, Seidlitz G, Gustavson K-H, Wilson PJ, Morris CP, Hopwood JJ, Pettersson U (1992) Molecular analysis of patients with Hunter syndrome: implications of a region prone to structural alterations within the IDS gene. Hum Mol Genet 1:195–198
Steglich C, Bunge S, Hulsebos T, Beck M, Brandt NJ, Schwinger E, Hopwood JJ, Gal A (1993) Molecular analysis of patients with mucopolysaccharidosis type II suggest that DXS466 maps within the Hunter gene. Hum Genet 92:179–182
Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Lements PR, Hopwood JJ (1990) Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 87:8531–8535
Wilson PJ, Meaney CA, Hopwood JJ, Morris CP (1993) Sequence of the human iduronate-2-sulfatase (IDS) gene. Genomics 17:773–775
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rathmann, M., Bunge, S., Steglich, C. et al. Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet 95, 34–38 (1995). https://doi.org/10.1007/BF00225070
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00225070